Abstract
Thyroid carcinoma is the most frequent endocrine malignancy and accounts for around 3% of global cancer incidence. Different histologies and clinical scenarios make necessary a multidisciplinary approach that includes new diagnostic methods and surgical, radiopharmaceutical and systemic therapies. This guideline updates several aspects of management of thyroid cancer.
Keywords
Multidisciplinary; Systemic therapy; Thyroid cancer
Bibliographic citation
Gallardo E, Medina J, Sánchez JC, Viúdez A, Grande E, Porras I, et al. SEOM clinical guideline thyroid cancer (2019). Clin Transl Oncol. 2020 Feb;22:223–235.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/6314This item appears in following collections
- HVH - Articles científics [2504]
- VHIO - Articles científics [743]
The following license files are associated with this item: